Abstract
Salmonellaenterica serovar Kentucky is an emergent human pathogen. Human infection with ciprofloxacin-resistant S. enterica Kentucky ST198 has been reported in Europe and North America as a consequence of travel to Asia/the Middle East. This is, to the best of our knowledge, the first study reporting the identification of this epidemic clone in India and South Asia.
Keywords:
India; antimicrobial resistance; fluoroquinolone; non-typhoidal Salmonella; whole-genome sequencing.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use
-
Ciprofloxacin / pharmacology*
-
Ciprofloxacin / therapeutic use
-
DNA, Bacterial / genetics
-
Drug Resistance, Bacterial*
-
Humans
-
India / epidemiology
-
Phylogeny
-
Salmonella Infections, Animal / drug therapy
-
Salmonella Infections, Animal / epidemiology*
-
Salmonella Infections, Animal / microbiology*
-
Salmonella enterica / classification
-
Salmonella enterica / drug effects*
-
Salmonella enterica / genetics
-
Salmonella enterica / isolation & purification*
-
Serogroup
-
Whole Genome Sequencing
Substances
-
Anti-Bacterial Agents
-
DNA, Bacterial
-
Ciprofloxacin